The Huberman Lab
The Huberman Lab

Female Hormone Health, Fertility & Vitality | Dr. Natalie Crawford

In this episode, my guest is Natalie Crawford, MD, a double board-certified physician specializing in obstetrics and gynecology, fertility and reproductive health and host of the “As a Woman” podcast. We discuss female hormones, nutrition, supplementation, reproductive health, and fertility, includi

Featured Speakers

Scicomm Media Host

Topics Discussed

Episode Summary

Executive Summary: Andrew Huberman and Dr. Natalie Crawford deliver a detailed masterclass on female reproductive biology, from fetal egg development through puberty, cycling, fertility testing, contraception, IVF, egg freezing, supplements, and menopause. A central theme is that ovarian reserve declines with age but egg quality—not just egg count—drives fertility, and many common fears about birth control or egg retrieval harming future fertility are misconceptions.

Main Topics: Female reproductive development and puberty (Priority: 5/5): Explains fetal egg formation, the hormonal sequence of puberty, secondary sex characteristics, and why earlier menarche does not shorten reproductive lifespan. Menstrual cycle physiology and fertility timing (Priority: 5/5): Breaks down follicular vs luteal phases, cycle regularity, ovulation timing, fertile window, libido changes, and ovulatory pain. Ovarian reserve, AMH, and egg freezing (Priority: 5/5): Clarifies that egg retrieval does not deplete the ovarian vault, discusses AMH and antral follicle count, and argues for earlier fertility assessment and egg freezing when appropriate. Birth control and reproductive health (Priority: 5/5): Reviews combined oral contraceptives, IUDs, Depo-Provera, and their effects on ovulation, AMH, bleeding patterns, clot risk, and long-term fertility. IVF, ICSI, and embryo selection (Priority: 5/5): Describes stimulation protocols, egg retrieval, ICSI, embryo culture, PGT, and why modern frozen embryo transfer has improved outcomes. Nutrition, supplements, and lifestyle (Priority: 4/5): Covers sleep, inflammation, diet quality, vitamin D, omega-3s, CoQ10, L-carnitine, inositol, and avoidance of smoking, vaping, cannabis, and excess alcohol. Menopause and hormone replacement (Priority: 4/5): Discusses perimenopause, earlier menopause risk factors, symptoms of low estrogen, and the benefits and timing of hormone replacement therapy.

Key Arguments: Eggs are created before birth and continually lost from a finite ovarian reserve; ovulation does not cause the main depletion of the egg supply. Earlier puberty or earlier menarche does not mean earlier menopause; reproductive lifespan is driven more by the original egg pool and later egg quality. Egg freezing and IVF do not reduce future fertility because they use eggs that were already recruited from the vault that month. Birth control pills suppress ovulation but do not permanently damage fertility; they can temporarily lower AMH and may help conditions like endometriosis or PCOS. The menstrual cycle is a vital sign: regularity and predictability matter more than the exact number of days, and shortening cycles can signal declining ovarian reserve. Egg quality declines with age due to rising aneuploidy, which is why fertility drops sharply after the late 30s even if ovulation continues. Modern frozen embryo transfer is preferred over fresh transfer because it avoids the high-hormone uterine environment that can worsen outcomes. Lifestyle factors that reduce inflammation—sleep, healthy diet, avoiding smoking/vaping/cannabis, and moderating alcohol—support fertility in both sexes. Menopause is not just the end of periods; low estrogen affects brain, bone, cardiovascular, vaginal, and overall health, and timely hormone replacement can be beneficial. Sperm quality is also affected by age and exposures, but unlike eggs, sperm are continuously produced, making male fertility more modifiable over time.

Data Points: Peak fetal egg count: 6–7 million eggs - Female fetus at about 20 weeks gestation has the highest egg number ever seen. Egg loss by birth: More than half lost before birth - Egg count declines substantially before a baby is born. Breast development before menarche: About 2 years - Thelarche typically precedes first period by roughly two years. Typical menarche shift: From about 13–15 years to about 10–11 years - Speaker describes earlier puberty/menarche trends in recent decades. Normal cycle length range: 21–35 days - A cycle can be normal within this range if it is consistent for the individual. Luteal phase length: 12–14 days - The luteal phase is described as relatively fixed across cycles. Fertile window: 5 days ending on ovulation day - Sperm can survive up to five days; egg survives about 24 hours. Egg survival after freeze-thaw: About 90% - Modern egg freezing has improved substantially over the last decade. Embryo survival after freeze-thaw: About 99% - Embryos are more robust than eggs during freezing and thawing. AMH suppression on birth control: Up to 30% lower - AMH can be artificially suppressed in people taking combined oral contraception. Antral follicle count at age 30: 16–20 total follicles - Approximate expected ultrasound count in a typical 30-year-old. Antral follicle count at age 35: 14–16 total follicles - Expected decline in ovarian reserve with age. Antral follicle count at age 40: 8–10 total follicles - Ovarian reserve drops more sharply after the late 30s. Antral follicle count at age 44: 2–4 total follicles - Very low expected reserve in the mid-40s. Optimal age for egg freezing: 32–33 years - Presented as the best average time to intervene if family building is not imminent. Age-related fertility decline: Sharp after 37 - Both egg quantity and quality worsen substantially after this age. Pregnancy chance at age 43: Less than 3% per month - Natural fecundability example given during counseling discussion. Miscarriage risk at age 40: 40% - Used to illustrate age-related increase in pregnancy loss. Ovarian cancer risk reduction with 10 years of pill use: More than 90% lower - Combined oral contraception strongly reduces ovarian cancer risk. IVF fertilization rate: About 75% - Approximate proportion of eggs expected to fertilize in a typical cycle. Blastocyst progression from fertilized eggs: About 50% - Rough estimate of embryos reaching blastocyst stage after fertilization. Live birth chance per euploid embryo transfer: About 65% - Used for genetically normal embryos after PGT. Cumulative live birth after 2 euploid transfers: About 88% - Illustrates high cumulative success with repeated single-embryo transfers. Cumulative live birth after 3 euploid transfers: About 95% - Shows low recurrent implantation failure after multiple transfers. Monozygotic twinning with IVF: 2%–3% - Higher than natural conception due to embryo manipulation. Natural monozygotic twinning rate: 0.03% - Baseline comparison for IVF-related twinning risk. Advanced paternal age risk signal: Age 50+ - Autism and some other risks were described as most strongly associated with older paternal age. Depo-Provera contraceptive duration: 3 months proven, up to 18 months effect - Injection can suppress ovulation long after the last shot. Sperm production cycle: About 72 days plus 18 days transit - Used to explain why male fertility responds over roughly 90 days. Sperm abstinence before semen analysis: 48–72 hours - Standard collection window for interpreting semen parameters. Vitamin D suggestion: 1,000 IU daily - General reproductive-health supplementation recommendation. Omega-3 suggestion: 1 gram daily - Recommended for fertility and anti-inflammatory support. CoQ10 suggestion: 200 mg three times daily - Suggested for egg and sperm mitochondrial support. L-carnitine suggestion for male fertility: 1 gram daily - Used with vitamin C and a multivitamin for abnormal sperm parameters. Vitamin C suggestion for male fertility: 1 gram daily - Part of the male fertility supplement protocol. Myo-inositol suggestion for PCOS: 2,000 mg - Recommended to improve insulin sensitivity and support ovulation in PCOS. Cost of AMH test: $79 - Approximate out-of-pocket cost mentioned for ovarian reserve blood testing.

Pivotal Quotes: "You’re making the withdrawal no matter what." — Dr. Natalie Crawford: Explaining that egg retrieval for IVF or freezing does not deplete future ovarian reserve beyond the normal monthly loss. "Your period’s a vital sign." — Dr. Natalie Crawford: Describing menstrual regularity and predictability as a key indicator of hormonal communication and ovarian health. "The female brain loves estrogen." — Dr. Natalie Crawford: Used to explain why higher-estrogen phases are associated with better mood, energy, and focus.

Implications: Listeners should understand that fertility is shaped by age, egg quality, inflammation, and lifestyle long before pregnancy is planned. Earlier testing and informed choices about freezing eggs, contraception, and hormone support can preserve options and improve outcomes.

🔓 Sign Up for Unlimited Episode Search

About The Huberman Lab

The Huberman Lab podcast is hosted by Andrew Huberman, Ph.D., a neuroscientist and tenured professor in the department of neurobiology, and by courtesy, psychiatry and behavioral sciences at Stanford School of Medicine. The podcast discusses neuroscience and science-based tools, including how our brain and its connections with the organs of our body control our perceptions, our behaviors, and our health, as well as existing and emerging tools for measuring and changing how our nervous system works. Huberman has made numerous significant contributions to the fields of brain development, brain function, and neural plasticity, which is the ability of our nervous system to rewire and learn new behaviors, skills, and cognitive functioning. He is a McKnight Foundation and Pew Foundation Fellow and was awarded the Cogan Award, given to the scientist making the most significant discoveries in the study of vision, in 2017. Work from the Huberman Laboratory at Stanford School of Medicine has been published in top journals, including Nature, Science, and Cell, and has been featured in TIME, BBC, Scientific American, Discover, and other top media outlets. In 2021, Dr. Huberman launched the Huberman Lab podcast. The podcast is frequently ranked in the top 10 of all podcasts globally and is often ranked #1 in the categories of Science, Education, and Health & Fitness.

View all episodes from The Huberman Lab